SCHEMBL3464902

SCHEMBL3464902

CC[C@@H](N)c1cncc(Br)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
HTT P42858 2/20 0.38
RAB9A P51151 1/20 0.38
POLB P06746 1/20 0.37
HCAR2 Q8TDS4 1/20 0.37
SLC6A4 P31645 1/20 0.36
MAPT P10636 2/20 0.36
MEN1 O00255 2/20 0.36
LMNA P02545 2/20 0.36
GAA P10253 2/20 0.36
KMT2A Q03164 2/20 0.36
ALDH1A1 P00352 1/20 0.36
TP53 P04637 1/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP2A6 P11509 1/20 0.34
S1PR1 P21453 1/20 0.34
S1PR3 Q99500 1/20 0.34
PKM P14618 1/20 0.34
OPRM1 P35372 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2400040 1.00 KDM4E (0.41) KDM4EHTTRAB9APOLBHCAR2
SCHEMBL3465641 1.00 KDM4E (0.41) KDM4EHTTRAB9APOLBHCAR2
Hydrochloric Acid SCHEMBL31226861 0.98 KDM4E (0.40) KDM4EHTTRAB9APOLBHCAR2
SCHEMBL2400728 0.85 KDM4E (0.39) KDM4EHTTRAB9APOLBHCAR2
SCHEMBL3466815 0.85 KDM4E (0.39) KDM4EHTTRAB9APOLBHCAR2
SCHEMBL24767550 0.78 ALDH1A1 (0.49) KDM4EHTTRAB9APOLBHCAR2
SCHEMBL31226405 0.78 KDM4E (0.35) KDM4EPOLBHCAR2
SCHEMBL14211406 0.78 POLB (0.36) KDM4EHTTRAB9APOLBHCAR2
SCHEMBL3465480 0.78 POLB (0.36) KDM4EHTTRAB9APOLBHCAR2
SCHEMBL29934066 0.78 POLB (0.36) KDM4EHTTRAB9APOLBHCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346868-B1 AZAINDAZOLE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INT (DE) 2016-01-27 EP disclosed
US-8338610-B2 Pyridinyl compounds useful as intermediates BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-12-25 US disclosed
US-20120136158-A1 Pyridinyl Compounds Useful As Intermediates BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-05-31 US disclosed
US-20100093724-A1 Azaindazole Compounds As CCR1 Receptor Antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093724-A1 Azaindazole Compounds As CCR1 Receptor Antagonists CCR1, CCR3, CCR4 KDM4E 2535/4885HTT 4591/4885RAB9A 2908/4885
US-20120136158-A1 Pyridinyl Compounds Useful As Intermediates CCR1, CCRL2, CCR4 KDM4E 4454/4885HTT 4365/4885RAB9A 2271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.